Academician Chen Zijiang won the Walter Futterweit Clinical Research Excellence Award
On October 5-7, 2023, coinciding with the 20th anniversary of the release of the Rotterdam diagnostic criteria for polycystic ovary syndrome (PCOS), the AE-PCOS conference was held in Rotterdam, Netherlands. Academician Chen Zijiang was awarded the Walter Futterweit Clinical Research Excellence Award for his outstanding contributions in the research and clinical practice of polycystic ovary syndrome...
Zhongshan Hospital's Clinical Research Achieves Another Major Breakthrough
Recently, the team of Li Xiaoying and Chen Ying from the Endocrinology Department of Sun Yat sen Hospital affiliated to Fudan University, together with the team of Professor Wang Guangyu from Beijing University of Posts and Telecommunications, published research results online in the international top medical journal NatureMedicine (natural medicine) - the first international proposal to adopt the AI system "RL-DITR" based on strong chemical learning algorithm to formulate insulin decision-making strategies, effectively improving the accuracy of insulin treatment programs for patients with type 2 diabetes. The research results can provide personalized and dynamic diagnosis and treatment programs for patients with type 2 diabetes, assist in establishing a hierarchical diagnosis and treatment system, and improve the efficiency of chronic disease management...
Notice of Clinical Trial Approval for Recombinant Human Adenovirus 5 Injection of Shanghai Pharmaceuticals Group Co., Ltd. Restructuring
Recombinant human adenovirus type 5 injection (trade name: Ankrui) is an oncolytic adenovirus anti-tumor drug that contains recombinant adenoviruses that can specifically replicate in tumor cells, cause tumor cell damage, lysis, and further activate immune responses to exert anti-tumor effects. Ankeri was approved for marketing in China in 2005, with an approved indication for advanced nasopharyngeal carcinoma...
Microorganisms are expected to become a weapon against cancer! Related drugs have entered clinical trials
Reporter of Science and Technology Daily Liu XiaSalmonella usually causes food poisoning, but in 2019, 71 year old Canadian Irit Barbour volunteered to drink a bottle of liquid containing 1 billion active Salmonella typhimurium as the last resort to fight pancreatic cancer. At that time, pancreatic cancer had spread to other organs in her body, and she could only live for a few months...
Human tooth regeneration is not a dream? The world's first "tooth regeneration" drug will undergo clinical trials
For humans, teeth are a very precious organ. In nature, fierce animals like big sharks constantly change their teeth throughout their lives, while humans only have two opportunities to grow teeth in their lifetime, one is deciduous and the other is permanent...
The Gates Foundation announced its support for the launch of phase III clinical trial of tuberculosis candidate vaccine
On June 28, the Wellcome Trust and the Bill and Melinda French Gates Foundation announced that they would provide funds to support the phase III clinical trial of tuberculosis candidate vaccine M72/AS01E (M72). If proved effective, M72 is expected to become the first new vaccine to prevent tuberculosis since the BCG vaccine vaccine was introduced in 1921...